AS
ATRC icon

Altshuler Shaham’s AtriCure ATRC Stock Holding History

Altshuler Shaham’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-657
Closed -$46K – 537
2021
Q3 		$46K Sell
657
-809
-55% -$62.3K ﹤0.01% 428
2021
Q2 		$116K Buy
1,466
+858
+141% +$62.4K ﹤0.01% 300
2021
Q1 		$40K Buy
+608
New +$37.4K ﹤0.01% 322
2020
Q3 		– Sell
-1,038
Closed -$47K – 379
2020
Q2 		$47K Buy
1,038
+240
+30% +$10.4K ﹤0.01% 196
2020
Q1 		$27K Buy
+798
New +$28.7K ﹤0.01% 214
2019
Q2 		– Sell
-269
Closed -$7K – 364
2019
Q1 		$7K Buy
269
+15
+6% +$456 ﹤0.01% 278
2018
Q4 		$8K Buy
254
+49
+24% +$1.53K ﹤0.01% 186
2018
Q3 		$7K Buy
+205
New +$6.49K ﹤0.01% 195

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Altshuler Shaham's ATRC Position: Q4 2021 in Review

Altshuler Shaham sold out of AtriCure (ATRC) in Q4 2021, closing a stake of 657 shares — an estimated $46K sold.

Altshuler Shaham first reported a position in ATRC in Q3 2018 and held it in 8 quarters. The position peaked at $116K in Q2 2021. 217 funds tracked by Wall St. Rank hold ATRC as of Q4 2021.

  • Altshuler Shaham reported no remaining AtriCure position as of Q4 2021 after selling out during the quarter.
  • Altshuler Shaham sold 657 AtriCure shares in Q4 2021, an estimated $46K.
  • Altshuler Shaham first reported a position in AtriCure in Q3 2018 and held it in 8 quarters.
  • Altshuler Shaham's AtriCure position peaked at $116K in Q2 2021.
  • 217 funds tracked by Wall St. Rank held AtriCure as of Q4 2021.

Based on Altshuler Shaham's 13F filing for Q4 2021, filed 15 Feb 2022.